La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Hapvida Participações e Investimentos Résultats passés
Passé contrôle des critères 0/6
Les bénéfices de Hapvida Participações e Investimentos ont diminué à un taux annuel moyen de -62.6%, tandis que le secteur Healthcare a vu ses bénéfices augmenter de en à 17% par an. Les revenus ont augmenté de en à un taux moyen de 33.6% par an.
Informations clés
-62.6%
Taux de croissance des bénéfices
-61.7%
Taux de croissance du BPA
| Healthcare Croissance de l'industrie | 11.6% |
| Taux de croissance des recettes | 33.6% |
| Rendement des fonds propres | -1.1% |
| Marge nette | -2.0% |
| Prochaine mise à jour des résultats | 07 Nov 2024 |
Mises à jour récentes des performances passées
Recent updates
Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Pretty Healthy Balance Sheet
Jul 16
Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Popularity With Investors Is Under Threat From Overpricing
Apr 28Is Hapvida Participações e Investimentos (BVMF:HAPV3) A Risky Investment?
Mar 28Investors Still Waiting For A Pull Back In Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)
Jan 07Hapvida Participações e Investimentos (BVMF:HAPV3) Is Making Moderate Use Of Debt
Dec 11Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
Sep 11Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
Jun 08Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Can Afford Some Debt
Feb 27Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Somewhat Strained Balance Sheet
Nov 11At R$8.13, Is It Time To Put Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) On Your Watch List?
Sep 11Here's Why Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Meaningful Debt Burden
Jul 08Is Now The Time To Look At Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)?
Mar 27We Think Hapvida Participações e Investimentos (BVMF:HAPV3) Is Taking Some Risk With Its Debt
Dec 28Is Now The Time To Look At Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3)?
Nov 23Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
Sep 10Should You Think About Buying Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Now?
Aug 06Does Hapvida Participações e Investimentos (BVMF:HAPV3) Have A Healthy Balance Sheet?
May 12The Hapvida Participações e Investimentos S.A. (BVMF:HAPV3) Annual Results Are Out And Analysts Have Published New Forecasts
Mar 20Introducing Hapvida Participações e Investimentos (BVMF:HAPV3), A Stock That Climbed 55% In The Last Year
Mar 10Hapvida Participações e Investimentos (BVMF:HAPV3) Has A Pretty Healthy Balance Sheet
Feb 11
Is Hapvida Participações e Investimentos S.A.'s (BVMF:HAPV3) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Jan 07Investors Who Bought Hapvida Participações e Investimentos (BVMF:HAPV3) Shares A Year Ago Are Now Up 34%
Dec 10Ventilation des recettes et des dépenses
Comment Hapvida Participações e Investimentos gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Jun 24 | 27,335 | -555 | 1,410 | 0 |
| 31 Mar 24 | 27,976 | -461 | 1,401 | 0 |
| 31 Dec 23 | 27,770 | -759 | 1,543 | 0 |
| 30 Sep 23 | 15,641 | -1,993 | 17 | 0 |
| 30 Jun 23 | 15,080 | -1,751 | 214 | 0 |
| 31 Mar 23 | 20,085 | -1,776 | 1,336 | 0 |
| 31 Dec 22 | 23,812 | -1,720 | 2,004 | 0 |
| 30 Sep 22 | 19,845 | -261 | 5,177 | 0 |
| 30 Jun 22 | 16,083 | -252 | 4,049 | 0 |
| 31 Mar 22 | 12,402 | 166 | 3,079 | 0 |
| 31 Dec 21 | 9,883 | 498 | 2,554 | 0 |
| 30 Sep 21 | 9,558 | 389 | 2,451 | 0 |
| 30 Jun 21 | 9,125 | 595 | 2,307 | 0 |
| 31 Mar 21 | 8,799 | 769 | 2,163 | 0 |
| 31 Dec 20 | 8,555 | 783 | 2,071 | 0 |
| 30 Sep 20 | 8,067 | 901 | 1,769 | 0 |
| 30 Jun 20 | 7,256 | 865 | 1,590 | 0 |
| 31 Mar 20 | 6,456 | 809 | 1,329 | 0 |
| 31 Dec 19 | 5,634 | 850 | 1,118 | 0 |
| 30 Sep 19 | 5,060 | 875 | 982 | 0 |
| 30 Jun 19 | 4,908 | 852 | 898 | 0 |
| 31 Mar 19 | 4,411 | 714 | 852 | 0 |
| 31 Dec 18 | 4,576 | 787 | 951 | 0 |
| 30 Sep 18 | 4,408 | 1,201 | 835 | 0 |
| 31 Mar 18 | 4,383 | 768 | 796 | 0 |
| 31 Dec 17 | 3,848 | 649 | 805 | 0 |
| 31 Dec 16 | 3,036 | 457 | 680 | 0 |
| 31 Dec 15 | 2,459 | 301 | 617 | 0 |
| 31 Dec 14 | 1,964 | 270 | 437 | 0 |
Des revenus de qualité: HAPV3 n'est actuellement pas rentable.
Augmentation de la marge bénéficiaire: HAPV3 n'est actuellement pas rentable.
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: HAPV3 n'est pas rentable et les pertes ont augmenté au cours des 5 dernières années à un rythme de 62.6% par an.
Accélération de la croissance: Impossible de comparer la croissance des bénéfices de HAPV3 au cours de l'année écoulée à sa moyenne sur 5 ans car elle n'est actuellement pas rentable
Bénéfices par rapport au secteur d'activité: HAPV3 n'est pas rentable, ce qui rend difficile la comparaison de sa croissance des bénéfices de l'année écoulée avec celle du secteur Healthcare ( 65.6% ).
Rendement des fonds propres
ROE élevé: HAPV3 a un retour sur capitaux propres négatif ( -1.14% ), car il n'est actuellement pas rentable.